BR100 Decreased By (-0.25%)
BR30 Decreased By (-0.64%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.83 Decreased By ▼ -0.20 (-3.32%)
BML 57.90 Increased By ▲ 5.15 (9.76%)
BOP 33.79 Decreased By ▼ -0.46 (-1.34%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.79 Decreased By ▼ -0.55 (-4.46%)
FCCL 53.49 Decreased By ▼ -0.40 (-0.74%)
FCSC 5.40 Increased By ▲ 0.18 (3.45%)
FFL 17.84 Decreased By ▼ -0.19 (-1.05%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.11 Increased By ▲ 0.11 (1%)
KEL 8.02 Decreased By ▼ -0.09 (-1.11%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.40 Decreased By ▼ -0.65 (-0.74%)
NBP 184.24 Decreased By ▼ -2.24 (-1.2%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.25 Increased By ▲ 0.31 (0.78%)
PIAHCLA 26.12 Decreased By ▼ -0.05 (-0.19%)
PIBTL 17.14 Decreased By ▼ -0.18 (-1.04%)
PPL 228.73 Decreased By ▼ -4.05 (-1.74%)
PRL 34.49 Decreased By ▼ -0.46 (-1.32%)
PTC 67.54 Decreased By ▼ -0.02 (-0.03%)
SEARL 90.93 No Change ▼ 0.00 (0%)
SSGC 26.83 Decreased By ▼ -0.34 (-1.25%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.33 Increased By ▲ 0.57 (6.51%)
TREET 24.51 Decreased By ▼ -0.03 (-0.12%)
TRG 71.61 Decreased By ▼ -0.14 (-0.2%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
Markets

Sanofi backs 50pc dividend payout long-term

NEW YORK : Sanofi SA's chief executive said that the drug-maker can maintain its dividend at a 50 percent payout ratio o
Published September 19, 2011 Updated September 19, 2011 04:55pm

awsertNEW YORK: Sanofi SA's chief executive said that the drug-maker can maintain its dividend at a 50 percent payout ratio once it reaches that level and that large acquisitions are "completely off our radar screen."

"If you are going to make commitments on dividend policy you have to be prepared to make long term," Sanofi CEO Chris Viehbacher told Reuters in an interview on Monday.

The company, which is girding for generic competition for two of its top medicines, has said the dividend will go from its current 35 percent payout rate to the 50 percent range by no later than 2014.

Asked if Sanofi could maintain the dividend rate three or four years beyond 2014, Viehbacher said: "Oh yeah, we would move to 50 percent for a longer term."

The CEO also said he does not foresee significant generic competition to Sanofi's big-selling Lantus insulin for diabetics on the horizon, despite some concern by analysts that it could become vulnerable to generics by 2014.

Copyright Reuters, 2011

Comments

Comments are closed for this article.